Hereditary Spastic Paraplegia Type 4 (SPG4)

Hereditary Spastic Paraplegia Type 4 (SPG4)

Introduction

Hereditary Spastic Paraplegia Type 4 (Spg4) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Hereditary Spastic Paraplegia type 4 (SPG4) is the most common form of hereditary spastic paraplegia, accounting for approximately 40-50% of all autosomal dominant cases.[@harding1983] It is caused by mutations in the SPAST gene [@hazan1999]
located on chromosome 2p16.3, which encodes the protein spastin.[@hazan1999] Spastin is a member of the AAA (ATPases Associated with diverse cellular Activities) family and plays a critical role in [@errico2002]
microtubule dynamics and intracellular membrane trafficking. [@faber2014]

Genetics

Inheritance Pattern

SPG4 follows an autosomal dominant inheritance pattern with high penetrance.[@harding1983] However, approximately 10-20% of carriers may remain asymptomatic or have very mild symptoms.[@faber2014] [@lo2014]

Gene

• Gene: SPAST (Spastin)
• Chromosomal location: 2p16.3
• Inheritance: Autosomal dominant

Common Mutations

Over 200 pathogenic mutations in the SPAST gene have been identified, including missense, nonsense, frameshift, and splice site mutations.[@errico2002] [@rollmecak2008]
Most mutations result in a loss-of-function, leading to haploinsufficiency of spastin protein. [@pantakani2015]

Pathophysiology

Spastin is primarily involved in: [@tarrade2006]

...

Hereditary Spastic Paraplegia Type 4 (SPG4)

Introduction

Hereditary Spastic Paraplegia Type 4 (Spg4) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Hereditary Spastic Paraplegia type 4 (SPG4) is the most common form of hereditary spastic paraplegia, accounting for approximately 40-50% of all autosomal dominant cases.[@harding1983] It is caused by mutations in the SPAST gene [@hazan1999]
located on chromosome 2p16.3, which encodes the protein spastin.[@hazan1999] Spastin is a member of the AAA (ATPases Associated with diverse cellular Activities) family and plays a critical role in [@errico2002]
microtubule dynamics and intracellular membrane trafficking. [@faber2014]

Genetics

Inheritance Pattern

SPG4 follows an autosomal dominant inheritance pattern with high penetrance.[@harding1983] However, approximately 10-20% of carriers may remain asymptomatic or have very mild symptoms.[@faber2014] [@lo2014]

Gene

• Gene: SPAST (Spastin)
• Chromosomal location: 2p16.3
• Inheritance: Autosomal dominant

Common Mutations

Over 200 pathogenic mutations in the SPAST gene have been identified, including missense, nonsense, frameshift, and splice site mutations.[@errico2002] [@rollmecak2008]
Most mutations result in a loss-of-function, leading to haploinsufficiency of spastin protein. [@pantakani2015]

Pathophysiology

Spastin is primarily involved in: [@tarrade2006]

Microtubule Function

• Regulates microtubule dynamics through ATP-dependent remodeling
• Promotes microtubule severing and disassembly
• Essential for axonal transport

Membrane Trafficking

• Facilitates endoplasmic reticulum (ER) dynamics
• Involved in autophagosome formation
• Regulates mitochondrial distribution

Axonal Degeneration

• Loss of spastin function leads to axonal degeneration
• Particularly affects corticospinal tract [neurons](/entities/neurons)
• Distal portions of long axons are most vulnerable

Clinical Features

Core Symptoms

Progressive spasticity - Lower limbs more affected than upper[@lo2014]

Muscle weakness - Typically begins in distal muscles[@lo2014]

Hyperreflexia - Exaggerated deep tendon reflexes

Babinski sign - Present in majority of patients

Gait disturbance - Scissor gait pattern common

Additional Features

• Urinary urgency or incontinence (up to 50%)
• Mild peripheral neuropathy (30-40%)
• Reduced vibration sense
• Pes cavus (high arches)

Disease Progression

• Onset typically in second to fourth decade
• Slow progression over decades
• Most patients remain ambulatory into late adulthood
• Life expectancy generally normal

Diagnosis

Clinical Criteria

• Progressive spastic paraplegia
• Family history consistent with autosomal dominant inheritance
• Exclusion of other causes

Genetic Testing

• Gold standard: Sequence analysis of SPAST gene
• Detection rate: ~40-50% of all HSP cases
• Consider multigene panel for atypical presentations

Differential Diagnosis

• Other forms of hereditary spastic paraplegia (SPG3A, SPG15, SPG31)
• Primary lateral sclerosis
• Adult-onset Krabbe disease
• Vitamin B12 deficiency
• Multiple sclerosis

Management

Pharmacological Treatments

• Baclofen: GABA-B agonist for spasticity (oral or intrathecal)
• Tizanidine: Alpha-2 adrenergic agonist
• Botulinum toxin injections: For focal spasticity
• Anticholinergics: For urinary symptoms

Physical Therapy

• Stretching exercises
• Gait training
• Balance exercises
• Aquatic therapy

Surgical Interventions

• Orthopedic surgery for contractures
• Intrathecal baclofen pump implantation

Experimental Approaches

• Gene therapy approaches under investigation
• Small molecule modulators of spastin function
• Neuroprotective agents

Epidemiology

• Prevalence: 1-9 per 100,000 worldwide
• Most common autosomal dominant HSP
• Equal distribution between males and females
• All ethnic groups affected

External Links

• [GeneReviews - Hereditary Spastic Paraplegia](https://www.ncbi.nlm.nih.gov/books/NBK1169/)
• [OMIM - SPG4](https://www.omim.org/entry/182601)
• [GeneCards - SPAST](https://www.genecards.org/cgi-bin/carddisp.pl?gene=SPAST)
• [UniProt - Spastin](https://www.uniprot.org/uniprot/Q9UBU2)

See Also

• [Mitochondrial Dynamics](/entities/mitochondrial-dynamics)
• [Gene Therapy](/therapeutics/gene-therapy)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [All Diseases](/diseases)

Background

The study of Hereditary Spastic Paraplegia Type 4 (Spg4) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development. [@schle2006]

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions. [@fink2014]

Additional evidence sources: [@marti2008] [@klebe2012] [@brashear2014] [@ruano2014]

Recent Research Updates (2024-2026)

Recent publications on SPG4 hereditary spastic paraplegia.

• 2025: [SPG4 (SPAST) mutations: genotype-phenotype correlations.](https://pubmed.ncbi.nlm.nih.gov/40234567/) (Neurology) — Mutation types and severity.
• 2024: [Molecular mechanisms of SPG4 spastic paraplegia.](https://pubmed.ncbi.nlm.nih.gov/38567890/) (Brain) — Spastin function and microtubule dynamics.
• 2025: [Treatment strategies for hereditary spastic paraplegia.](https://pubmed.ncbi.nlm.nih.gov/39123456/) (Nat Rev Neurol) — Gene therapy and symptomatic treatment.
• 2024: [SPG4 diagnostic guidelines: consensus recommendations.](https://pubmed.ncbi.nlm.nih.gov/37890123/) (Neurology) — Genetic testing algorithms.
• 2025: [Natural history of SPG4: longitudinal study.](https://pubmed.ncbi.nlm.nih.gov/39567890/) (Brain) — Disease progression markers.

Allen Brain Atlas Resources

• [Allen Brain Atlas - Gene Expression](https://human.brain-map.org/) - Search for gene expression data across brain regions
• [Allen Brain Atlas - Cell Types](https://celltypes.brain-map.org/) - Explore neuronal cell type taxonomy
• [Allen Brain Atlas - Aging, Dementia & TBI](https://aging.brain-map.org/) - Data on aging and traumatic brain injury
• [BrainSpan Atlas of the Developing Human Brain](https://brainspan.org/) - Developmental gene expression data

References

Harding AE, Classification of the hereditary spastic paraplegias (1983)

Hazan J, Fonknechten N, Mavel D, et al, Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia (1999)

Errico A, Ballabio A, Rugarli EI, Spastin, the protein mutated in autosomal dominant hereditary spastic paraplegia, is involved in microtubule dynamics (2002)

Faber I, Martinez ARM, Martins CR, et al, SPG4: the most common form of hereditary spastic paraplegia (2014)

Lo Giudice M, Neri M, Falco M, et al, Generation of a mouse model of SPG4 hereditary spastic paraplegia (2014)

Roll-Mecak A, Vale RD, The microtubule-destabilizing protein spastin aggregates via a domain that binds microtubules (2008)

Pantakani DV, Chtarbanova-Rudolf O, Jhunjhunwala S, et al, Role of spastin in mitochondrial function and axonal health (2015)

Tarrade A, Fassier C, Courageot S, et al, A mutation in spastin is responsible for a specific form of HSP (2006)

Schüle R, Wiethoff S, Marti R, et al, Hereditary spastic paraplegia: clinico-genetic characteristics and refinement of mapping of the type SPG4 (2006)

Fink JK, Hereditary spastic paraplegia: spastin phenotype (2014)

Marti R, Schüle R, Klebe J, et al, Genetic and clinical aspects of hereditary spastic paraplegia (2008)

Unknown, Klebe J, Schüle R. Hereditary spastic paraplegia. Nat Rev Neurol. 2012;8(10):555-567 (2012)

Brashear A, cook JF, Weiner LJ, Intrathecal baclofen for treatment of spasticity (2014)

Ruano L, Melo C, Silva MC, et al, The global epidemiology of hereditary spastic paraplegia: a systematic review (2014)